LENZ Therapeutics, Inc. (LENZ) Misses Q1 EPS by 132c

LENZ Therapeutics, Inc. (NASDAQ: LENZ) reported Q1 EPS of ($1.32). Revenue for the quarter came in at $1.9 million.

For earnings history and earnings-related data on LENZ Therapeutics, Inc. (LENZ) click here.

You May Also Be Interested In

• Kalshi in early talks for IPO - The Information
• Happy Belly Food Group raises $8.35M through warrant exercises
• RBC Capital Upgrades Sunbelt Rentals (SUNB) to Sector Perform